InvaGen Pharmaceuticals Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 500

Employees

  • Latest Deal Type
  • Grant

  • Financing Rounds
  • 2

  • Investments
  • 2

InvaGen Pharmaceuticals General Information

Description

Developer of generic prescription medicines based in Hauppauge, New York. The company engages in the development, manufacturing, marketing and distribution of generic prescription medicines with a focus on a wide range of therapeutic areas including, cardiovascular, anti-infective, CNS, anti-inflammatory, anti-diabetic and anti-depressants, thereby providing patients with immediate-release and modified-release capsules and tablets.

Contact Information

Website
www.invagen.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 7 Oser Avenue
  • Hauppauge, NY 11788
  • United States
+1 (631)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Acquirer
Cipla
Vertical(s)
Manufacturing
Corporate Office
  • 7 Oser Avenue
  • Hauppauge, NY 11788
  • United States
+1 (631)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InvaGen Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore InvaGen Pharmaceuticals‘s full profile, request access.

Request a free trial

InvaGen Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of generic prescription medicines based in Hauppauge, New York. The company engages in the development, manufa
Pharmaceuticals
Hauppauge, NY
500 As of 2016

Rahway, NJ
 

Amman, Jordan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InvaGen Pharmaceuticals Competitors (61)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merck & Co. Corporation Rahway, NJ
MS Pharma Formerly PE-Backed Amman, Jordan
Tris Pharma Private Debt Financed Monmouth Junction, NJ
Glenmark Pharmaceuticals Corporation Mumbai, India
Biocon Formerly PE-Backed Bengaluru, India
You’re viewing 5 of 61 competitors. Get the full list »

InvaGen Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InvaGen Pharmaceuticals Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Avenue Therapeutics 08-Feb-2019 Pharmaceuticals
Avenue Therapeutics 13-Nov-2018 Merger/Acquisition Pharmaceuticals
To view InvaGen Pharmaceuticals’s complete investments and acquisitions history, request access »

InvaGen Pharmaceuticals FAQs

  • When was InvaGen Pharmaceuticals founded?

    InvaGen Pharmaceuticals was founded in 2003.

  • Who is the founder of InvaGen Pharmaceuticals?

    Sudhakar Vidiyala Ph.D is the founder of InvaGen Pharmaceuticals.

  • Where is InvaGen Pharmaceuticals headquartered?

    InvaGen Pharmaceuticals is headquartered in Hauppauge, NY.

  • What is the size of InvaGen Pharmaceuticals?

    InvaGen Pharmaceuticals has 500 total employees.

  • What industry is InvaGen Pharmaceuticals in?

    InvaGen Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is InvaGen Pharmaceuticals a private or public company?

    InvaGen Pharmaceuticals is a Private company.

  • What is InvaGen Pharmaceuticals’s current revenue?

    The current revenue for InvaGen Pharmaceuticals is .

  • Who are InvaGen Pharmaceuticals’s competitors?

    Merck & Co., MS Pharma, Tris Pharma, Glenmark Pharmaceuticals, and Biocon are some of the 61 competitors of InvaGen Pharmaceuticals.

  • When was InvaGen Pharmaceuticals acquired?

    InvaGen Pharmaceuticals was acquired on 01-Jun-2021.

  • Who acquired InvaGen Pharmaceuticals?

    InvaGen Pharmaceuticals was acquired by Cipla.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »